Decline depth
-24.2%
From rolling 252-day high of $28.00, 115d ago.
Past the 20% Watch threshold.
-24.2%
from rolling 252-day high of $28.00 set 2026-04-27 · 115d ago
Current
$21.23
Decline depth
-24.2%
Decline σ
4.4σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$JBIO landed on the list 2026-04-16, down 78.1% from its 52-week high that day — now down -24.2%.
That's 0.6 percentage points deeper than the day it joined. It bottomed 85.0% below that high along the way.
Decline from the 52-week high as it stood on 2026-04-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
JBIO qualifies for the Watch on decline depth.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 3/5 Watch threshold.
Decline sigma
4.4σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (3.94% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about JBIO.
JBIO qualifies for the Watch on decline depth — down -24.2% from its rolling 252-day high.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 4.4σ over 5 bars.
Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 2U (green).
Earnings on file: 2026-03-06. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about JBIO
What people ask.
Why is JBIO on Broken Stocks?
JBIO qualifies for the Watch on decline depth. It is down -24.2% from its rolling 252-day high of $28.00, set on 2026-04-27 — 115d ago.
Is JBIO a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. JBIO is down -24.2% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is JBIO a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is JBIO trading inside its 52-week range?
At $21.23, JBIO sits 68.3% of the way from its 52-week low ($6.67) to its 52-week high ($28.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has JBIO been declining?
The current 24.2% decline accrued over 115d, which annualizes to roughly -76.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does JBIO compare to its sector?
There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 35 Amber, 38 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — JBIO's decline is shallower than the sector median.
Does JBIO's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-03-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.